Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet’s Uveitis-Reference-Cited by-同舟云学术

Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet’s Uveitis

Published:2023-10-06 Issue: Volume: Page:1-4
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Tao Tianyu¹,He Daquan¹,Peng Xuening¹,Huang Zhaohao¹,Su Wenru¹²^ORCID

Affiliation:

1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China

2. Department of Uveitis, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China

Funder

National Outstanding Youth Science Fund Project of China

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2023.2263557

Reference22 articles.

1. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome

2. Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

3. Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet’s uveitis with vasculitis

4. Behcet's disease: a new target for anti-tumour necrosis factor treatment

5. Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances;Journal of Neuroinflammation;2024-05-22

2. Options for systemic therapy of uveitis including alternative therapies;Expert Review of Ophthalmology;2024-03-05